Published in BMC Med Genet on August 21, 2008
Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer. Curr Mol Med (2010) 1.17
The immunobiology of primary sclerosing cholangitis. Semin Immunopathol (2009) 1.15
ATG16L1 T300A polymorphism and Crohn's disease susceptibility: evidence from 13,022 cases and 17,532 controls. Hum Genet (2009) 1.11
Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS). PLoS One (2013) 0.90
Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity? PLoS One (2010) 0.89
T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: a meta-analysis. World J Gastroenterol (2010) 0.88
Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis. Int J Colorectal Dis (2011) 0.85
Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches. Clin Liver Dis (2015) 0.80
Contribution of the IBD5 locus to inflammatory bowel disease: a meta-analysis. Hum Genet (2011) 0.79
Frequency and risk factors of primary sclerosing cholangitis among patients with inflammatory bowel disease in North-East of Iran. Gastroenterol Hepatol Bed Bench (2015) 0.76
Interleukin-23 receptor genetic polymorphisms and Crohn's disease susceptibility: a meta-analysis. Inflamm Res (2010) 0.76
Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: A meta-analysis. Sci Rep (2015) 0.76
Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease. Sci Rep (2016) 0.75
NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients. Sci Rep (2017) 0.75
Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis. Clin Exp Med (2012) 0.75
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods (2007) 50.83
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Inflammatory bowel disease. N Engl J Med (2002) 21.17
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet (2006) 15.14
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest (2006) 11.89
STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem (2007) 10.41
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet (2006) 9.56
Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med (2006) 7.76
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2006) 7.75
Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet (2004) 5.83
CARD15 mutations in Blau syndrome. Nat Genet (2001) 5.79
Primary biliary cirrhosis. N Engl J Med (1996) 3.51
Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet (2004) 3.19
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology (2007) 2.97
Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood (2004) 2.32
The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe (2007) 2.26
IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine (2007) 1.93
Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol (2006) 1.68
rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One (2007) 1.48
Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J Exp Med (2004) 1.43
The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology (2005) 1.21
The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology (2002) 1.20
NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology (2002) 1.20
Genetics of the innate immune response in inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.05
Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun (2005) 0.96
Role of discs large homolog 5. World J Gastroenterol (2006) 0.93
Genes, diet and inflammatory bowel disease. Mutat Res (2007) 0.91
Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology (2001) 0.91
Genetic epidemiology of primary sclerosing cholangitis. World J Gastroenterol (2007) 0.90
Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease. Hum Mutat (2006) 0.88
How NOD2 mutations predispose to Crohn's disease? Microbes Infect (2007) 0.86
Epidemiology of primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol (2001) 0.84
Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. World J Gastroenterol (2005) 0.82
Primary biliary cirrhosis: solving the enigma. Ann N Y Acad Sci (2005) 0.79
The many roads to inflammatory bowel diseases. Immunity (2006) 0.78
Primary sclerosing cholangitis. J Gastroenterol Hepatol (2006) 0.76
hnRNP K: one protein multiple processes. Bioessays (2004) 2.96
Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One (2010) 2.32
Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene (2003) 1.83
The transcription factor encyclopedia. Genome Biol (2012) 1.28
Landscape of the hnRNP K protein-protein interactome. Proteomics (2006) 1.12
Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics. J Mol Med (Berl) (2007) 1.06
High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer. Fam Cancer (2012) 1.02
The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol (2005) 1.01
Cooperative binding of the hnRNP K three KH domains to mRNA targets. FEBS Lett (2004) 1.01
Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population. PLoS One (2012) 1.00
Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J Microbiol Methods (2003) 0.97
The fold recognition of CP2 transcription factors gives new insights into the function and evolution of tumor suppressor protein p53. Cell Cycle (2008) 0.96
An integrated LC-ESI-MS platform for quantitation of serum peptide ladders. Application for colon carcinoma study. Proteomics Clin Appl (2009) 0.94
Characterization of hnRNP K protein-RNA interactions. J Mol Biol (2004) 0.93
Comprehensive analysis of the palindromic motif TCTCGCGAGA: a regulatory element of the HNRNPK promoter. DNA Res (2010) 0.90
Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures. J Mol Med (Berl) (2006) 0.90
Heterogeneous nuclear ribonucleoprotein K enhances insulin-induced expression of mitochondrial UCP2 protein. J Biol Chem (2004) 0.90
Increased expression of ribosomal protein S2 in liver tumors, posthepactomized livers, and proliferating hepatocytes in vitro. Acta Biochim Pol (2002) 0.86
A common cis-element in promoters of protein synthesis and cell cycle genes. Acta Biochim Pol (2007) 0.86
1000 liver transplantations at the Department of General, Transplant and Liver Surgery, Medical University of Warsaw--analysis of indications and results. Pol Przegl Chir (2012) 0.86
The hppA gene of Helicobacter pylori encodes the class C acid phosphatase precursor. FEBS Lett (2002) 0.85
Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis. J Clin Lab Anal (2007) 0.84
Helicobacter pylori VacA cytotoxin interacts with fibronectin and alters HeLa cell adhesion and cytoskeletal organization in vitro. FEMS Immunol Med Microbiol (2005) 0.84
Helicobacter pylori protein oxidation influences the colonization process. Int J Med Microbiol (2006) 0.84
Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2005) 0.83
Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. Mitochondrion (2003) 0.82
Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles. Funct Integr Genomics (2013) 0.82
Up-regulation of human PNPase mRNA by beta-interferon has no effect on protein level in melanoma cell lines. Acta Biochim Pol (2006) 0.82
Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women. Neuro Endocrinol Lett (2010) 0.81
Common low-penetrance risk variants associated with breast cancer in Polish women. BMC Cancer (2013) 0.81
Association between gynecomastia and aromatase (CYP19) polymorphisms. Eur J Endocrinol (2008) 0.81
Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers. Acta Biochim Pol (2013) 0.81
Increased mitochondrial gene expression during L6 cell myogenesis is accelerated by insulin. Int J Biochem Cell Biol (2005) 0.81
Casein kinases phosphorylate multiple residues spanning the entire hnRNP K length. Biochim Biophys Acta (2006) 0.81
Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus. J Mol Med (Berl) (2007) 0.81
Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int (2013) 0.81
Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2004) 0.81
Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-α gene in acute kidney injury. PLoS One (2013) 0.80
Tip-alpha (hp0596 gene product) is a highly immunogenic Helicobacter pylori protein involved in colonization of mouse gastric mucosa. Curr Microbiol (2008) 0.80
The role of the SHH gene in prostate cancer cell resistance to paclitaxel. Prostate (2014) 0.80
The diverse involvement of heterogeneous nuclear ribonucleoprotein K in mitochondrial response to insulin. FEBS Lett (2006) 0.80
Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection. Przegl Epidemiol (2013) 0.79
Barrett's esophagus associates with a variant of IL23R gene. Acta Biochim Pol (2008) 0.79
Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients. J Alzheimers Dis (2012) 0.79
The binding activity of yeast RNAs to yeast Hek2p and mammalian hnRNP K proteins, determined using the three-hybrid system. Cell Mol Biol Lett (2005) 0.79
jChIP: a graphical environment for exploratory ChIP-Seq data analysis. BMC Res Notes (2014) 0.79
Gene expression alterations induced by low molecular weight heparin during bowel anastomosis healing in rats. Acta Biochim Pol (2011) 0.79
Multivariate analysis of risk factors for development of duodenal ulcer in Helicobacter pylori-infected patients. Digestion (2003) 0.78
Halogenated imidazole derivatives block RNA polymerase II elongation along mitogen inducible genes. BMC Mol Biol (2010) 0.78
Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis. Acta Biochim Pol (2007) 0.78
Lack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors. Int Urol Nephrol (2011) 0.78
Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice. J Cell Mol Med (2014) 0.77
Mitochondria-associated satellite I RNA binds to hnRNP K protein. Acta Biochim Pol (2006) 0.77
Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer. BMC Cancer (2008) 0.77
Comparative kinome analysis to identify putative colon tumor biomarkers. J Mol Med (Berl) (2011) 0.77
Two-stage model-based clustering for liquid chromatography mass spectrometry data analysis. Stat Appl Genet Mol Biol (2009) 0.76
CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients. Med Oncol (2014) 0.76
Inferring serum proteolytic activity from LC-MS/MS data. BMC Bioinformatics (2012) 0.76
Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence. J Immunoassay Immunochem (2013) 0.75
Association of autoimmune liver diseases. Eur J Gastroenterol Hepatol (2004) 0.75
Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer. Fam Cancer (2013) 0.75
Protective effect of vaccination with DNA of the H. Pylori genomic library in experimentally infected mice. Cell Mol Biol Lett (2004) 0.75